BioSig Technologies Reinvests in Lafayette College’s InternShift Progam
20 nov. 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Announces New Research Program with Mayo Clinic
13 nov. 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Ring NASDAQ Opening Bell on November 13, 2018
12 nov. 2018 14h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
BioSig Technologies to Present at the 4th Annual Dawson James Small Cap Growth Conference
29 oct. 2018 15h03 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
BioSig Technologies Begins Trading on Nasdaq
21 sept. 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM) a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Commence Trading on the Nasdaq
19 sept. 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM, OTCQB:BSGMD), a medical device company developing a proprietary biomedical signal processing platform...
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
28 mars 2018 02h00 HE
|
BioSig Technologies, Inc.
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
BioSig Technologies Enters into Strategic Development Work with Health Research International
11 juil. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, July 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...